• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$36.88 -$0.19 (-0.51%)

REAL-TIME: Last trade at

Medtronic, Inc.

NYSE:MDT

Building A Retirement Portfolio In A Tumultuous Time

St. Jude Remains Neutral - Analyst Blog

Supply Your Portfolio With Healthy Growth From Medical Suppliers

2 Promising Medical Companies Near Their Lows

My Rookie Season Writing Options: Bottom Of The First - Covered Calls

Will Stryker Help You Retire Rich?

UPDATE: Medtronic 4Q Profit Rose 28% On Fewer Charges, Sales Growth

2nd UPDATE: Medtronic 4Q Profit Rose 28% On Fewer Charges

Medtronic Posts Mixed Numbers - Analyst Blog

Medtronic Beats on Revenue, Matches Expectations on EPS

Earnings Preview: Medtronic - Analyst Blog

Where the Stock and Bond Bargains Are Hiding

FDA Approval for BSX Epic Stent - Analyst Blog

CE Mark for St. Jude's EnligHTN - Analyst Blog

Dividend Stocks Reporting Earnings Next Week

BSX Unveils Positive Data at EuroPCR - Analyst Blog

Boston Scientific Innova Has CE Mark - Analyst Blog

BSX Presentation at EuroPCR - Analyst Blog

Medtronic ICD Study Of Extended Detection Time Meets Endpoint

UPDATE: St Jude Defibrillator Lead Performed Worse Than Competitor-Study

St. Jude Wins Approval for Ellipse - Analyst Blog

Boston Scientific Stays at Neutral - Analyst Blog

DexCom Misses on EPS, Losses Mount - Analyst Blog

Good News for Edwards TAVR - Analyst Blog

Microsemi Offers Encouraging Outlook (revised) - Analyst Blog

Microsemi Beats The Zacks Consensus - Analyst Blog

Government Issues Reimbursement Decision On Edwards Life Valve

How to Tell if Medtronic Is Hiding Weakness

The Zacks Analyst Blog Highlights: St. Jude Medical, Abbott Laboratories, Medtronic, Boston Scientif

Integra Beats, Ups EPS Guidance - Analyst Blog

FDA Panel Backs Cameron Health Heart Defibrillator

St. Jude's Alliance with Abbott - Analyst Blog

Edwards Beats, Lowers 2012 View - Analyst Blog

Zacks' Voice of the People highlights opportunities with Apple, Google, Medtronic and JDS - Press Re

Earnings Preview: EW - Analyst Blog

CE Mark for St. Jude's Ellipse ICD - Analyst Blog

FDA Sees Higher Infection Rate In Study Of New Type Of Heart Defibrillator

FDA Nod for Integra Spine - Analyst Blog

2nd UPDATE: Boston Scientific Sees Higher Profits, Improving Heart Market

St. Jude Beats, Raises Guidance - Analyst Blog

See More Articles...